Boole
4
3M
2
0.50
1
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ProVerum Medical.
This Boole works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Boole, startups are often financed by Enterprise Ireland, Xenium Capital, MedTech Strategist. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, Xenium Capital, Irrus Investments. In the next rounds fund is usually obtained by Enterprise Ireland, Xenium Capital, Irrus Investments.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Health Care (4)
- Medical Device (4)
- Medical (2)
- Business Development (2)
- Investments by region
-
- Ireland (4)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Incereb | 01 Mar 2018 | Health Care, Medical Device, Medical, Business Development | Seed | 1M | Ireland, County Dublin, Ireland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.